scispace - formally typeset
M

Marjukka Myllärniemi

Researcher at University of Helsinki

Publications -  104
Citations -  3830

Marjukka Myllärniemi is an academic researcher from University of Helsinki. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Lung. The author has an hindex of 32, co-authored 98 publications receiving 3356 citations. Previous affiliations of Marjukka Myllärniemi include Helsinki University Central Hospital.

Papers
More filters
Journal ArticleDOI

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β

TL;DR: It is demonstrated that, after endothelial denudation of rat carotid artery, the mRNA of the classical estrogen receptor (ERα) is constitutively expressed at a low level whereas the expression of the novel ERβ mRNA increases >40-fold, suggesting that preferential targeting to ERβ will provide vasculoprotective estrogen analogs devoid of effects to the reproductive system.
Journal ArticleDOI

Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.

TL;DR: It is observed that the BMP antagonist, gremlin, is highly up-regulated in idiopathic pulmonary fibrosis (IPF), and analyses of cultured human bronchial epithelial cells indicated that asbestos-induced gremlin expression could be prevented by inhibitor of the TGF-beta receptor and also by inhibitors of the mitogen-activated protein kinase kinase/extracellular signal-regulatedprotein kinase pathways.
Journal ArticleDOI

Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species.

TL;DR: The oxidative effects of cigarette smoking have been found to activate TGF-beta in chronic obstructive pulmonary disease (COPD), a disease consisting of emphysema, airway fibrosis, and focal lung fibrosis.
Journal ArticleDOI

Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.

TL;DR: The overexpression of this developmental gene in IPF may be a key event in the persistence of myofibroblasts in the lung interstitium and provides a potential target for therapeutic intervention.
Journal ArticleDOI

Extracellular Superoxide Dismutase in Pulmonary Fibrosis

TL;DR: Extracellular SOD regulation in response to pulmonary fibrosis in animals and humans is discussed and possible mechanisms by which EC-SOD may protect against fibrosis are reviewed.